TRDA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 8.11%

Insider Buying (Last 12 Months): $1,352,567.90

Insider Selling (Last 12 Months): $5,867,281.75

Entrada Therapeutics Insider Trading History Chart

Entrada Therapeutics Share Price & Price History

^$10.16

▲ +0.09 (0.89%)

As of 12/4/2025 05:00 PM ET

Days: 30 | 90 | 365

Entrada Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/21/2025	Kory James Wentworth	CFO	Sell	8,910	$9.98	$88,921.80	110,026
11/14/2025	Kush Parmar	Director	Sell	200,000	$8.80	$1,760,000.00	2,963,066
11/14/2025	Ventures V L.P. 5Am	Major Shareholder	Sell	200,000	$8.80	$1,760,000.00	2,963,066
11/12/2025	Bros. Advisors Lp Baker	Major Shareholder	Buy	100,736	$7.76	$781,711.36	4,664,924
11/11/2025	Bros. Advisors Lp Baker	Major Shareholder	Buy	46,434	$7.50	$348,255.00	4,572,549
11/10/2025	Bros. Advisors Lp Baker	Major Shareholder	Buy	30,874	$7.21	$222,601.54	4,529,969
7/9/2025	Kush Parmar	Director	Sell	27,000	$7.50	$202,500.00	1,093,313
7/9/2025	Ventures V L.P. 5Am	Major Shareholder	Sell	20,065	$7.50	$150,487.50	3,163,066
7/9/2025	Ventures V L.P. 5Am	Major Shareholder	Sell	6,935	$7.50	$52,012.50	1,093,313
6/30/2025	Kush Parmar	Director	Sell	25,000	$6.81	$170,250.00	1,106,670
6/30/2025	Ventures V L.P. 5Am	Major Shareholder	Sell	18,578	$6.81	$126,516.18	3,201,709
6/30/2025	Ventures V L.P. 5Am	Major Shareholder	Sell	6,422	$6.81	$43,733.82	1,106,670
6/27/2025	Kush Parmar	Director	Sell	75,000	$6.91	$518,250.00	1,113,092
6/27/2025	Ventures V L.P. 5Am	Major Shareholder	Sell	55,735	$6.91	$385,128.85	3,220,287
6/27/2025	Ventures V L.P. 5Am	Major Shareholder	Sell	19,265	$6.91	$133,121.15	1,113,092
12/10/2024	Bioventures 2018 L.P. Mpm	Major Shareholder	Sell	22,935	$20.77	$476,359.95	4,402,849
12/2/2024	Kory James Wentworth	CFO	Sell	5,000	$20.00	$100,000.00	73,849
11/29/2024	Kory James Wentworth	CFO	Sell	1,000	$19.97	$19,970.00	73,849
11/13/2024	Natarajan Sethuraman	Insider	Sell	2,700	$20.04	$54,108.00	160,888
11/11/2024	Kory James Wentworth	CFO	Sell	8,637	$19.98	$172,567.26	73,849
11/11/2024	Natarajan Sethuraman	Insider	Sell	1,409	$20.01	$28,194.09	163,588
10/16/2024	Natarajan Sethuraman	Insider	Sell	600	$18.00	$10,800.00	183,216
9/26/2024	Nathan J. Dowden	COO	Sell	847	$16.00	$13,552.00	125,149
9/9/2024	Kory James Wentworth	CFO	Sell	3,195	$14.97	$47,829.15	76,486
9/9/2024	Natarajan Sethuraman	Insider	Sell	2,642	$15.09	$39,867.78	183,816
9/9/2024	Nathan J. Dowden	COO	Sell	1,904	$15.07	$28,693.28	125,996
9/6/2024	Natarajan Sethuraman	Insider	Sell	600	$15.24	$9,144.00	186,458
9/6/2024	Nathan J. Dowden	COO	Sell	399	$15.19	$6,060.81	127,900
7/15/2024	Dipal Doshi	CEO	Sell	1,600	$17.81	$28,496.00	334,475
7/15/2024	Natarajan Sethuraman	Insider	Sell	638	$18.00	$11,484.00	188,814
7/12/2024	Dipal Doshi	CEO	Sell	300	$18.00	$5,400.00	336,075
7/12/2024	Natarajan Sethuraman	Insider	Sell	600	$18.00	$10,800.00	189,452
7/8/2024	Kory James Wentworth	CFO	Sell	1,758	$14.95	$26,282.10	81,412
6/13/2024	Dipal Doshi	CEO	Sell	1,000	$16.17	$16,170.00	336,375
5/20/2024	Natarajan Sethuraman	Insider	Sell	9,675	$15.19	$146,963.25	190,052
5/16/2024	Dipal Doshi	CEO	Sell	1,800	$15.00	$27,000.00	338,575
5/16/2024	Natarajan Sethuraman	Insider	Sell	1,000	$15.00	$15,000.00	208,032
5/8/2024	Peter S Kim	Director	Buy	2,276	$14.04	$31,955.04	65,212
4/8/2024	Peter S Kim	Director	Buy	2,600	$13.57	$35,282.00	62,936
3/28/2024	Peter S Kim	Director	Buy	1,512	$13.75	$20,790.00	60,336
3/25/2024	Peter S Kim	Director	Buy	3,180	$13.36	$42,484.80	56,074
3/21/2024	Peter S Kim	Director	Buy	704	$13.24	$9,320.96	49,776
3/19/2024	Peter S Kim	Director	Buy	900	$12.66	$11,394.00	47,944
2/15/2024	Dipal Doshi	CEO	Sell	1,000	$15.00	$15,000.00	243,279
1/16/2024	Dipal Doshi	CEO	Sell	1,000	$15.99	$15,990.00	244,279
12/26/2023	Kory James Wentworth	CFO	Sell	94	$16.67	$1,566.98	49,571
12/22/2023	Kory James Wentworth	CFO	Sell	10,206	$15.69	$160,132.14	49,571
12/20/2023	Dipal Doshi	CEO	Sell	1,000	$15.00	$15,000.00	245,279
11/13/2023	Dipal Doshi	CEO	Sell	1,000	$16.23	$16,230.00	246,279
10/17/2023	Dipal Doshi	CEO	Sell	1,000	$15.00	$15,000.00	247,279
9/13/2023	Dipal Doshi	CEO	Sell	1,000	$15.00	$15,000.00	248,279
9/6/2023	Kory James Wentworth	CFO	Sell	950	$13.48	$12,806.00	49,571
9/6/2023	Nathan J. Dowden	COO	Sell	972	$13.47	$13,092.84	48,168
9/6/2023	Nerissa Kreher	Insider	Sell	892	$13.48	$12,024.16	40,037
8/14/2023	Dipal Doshi	CEO	Sell	1,000	$15.67	$15,670.00	201,069
8/4/2023	Nerissa Kreher	Insider	Sell	6,898	$14.14	$97,537.72	27,130
8/2/2023	Nerissa Kreher	Insider	Sell	10,348	$15.19	$157,186.12	27,130
7/11/2023	Kory James Wentworth	CFO	Sell	3,884	$18.00	$69,912.00	36,747
7/10/2023	Natarajan Sethuraman	Insider	Sell	3,026	$18.00	$54,468.00	168,299
7/10/2023	Nathan J. Dowden	COO	Sell	3,200	$18.00	$57,600.00	39,273
6/22/2023	Nathan J. Dowden	COO	Sell	7,097	$16.02	$113,693.94	42,473
6/21/2023	Kory James Wentworth	CFO	Sell	17,500	$15.01	$262,675.00	27,957
6/20/2023	Nathan J. Dowden	COO	Sell	8,885	$14.94	$132,741.90	49,570
4/27/2023	Dipal Doshi	CEO	Sell	2,000	$13.71	$27,420.00	202,069
4/17/2023	Dipal Doshi	CEO	Sell	2,092	$18.01	$37,676.92	204,069
4/17/2023	Natarajan Sethuraman	Insider	Sell	3,961	$18.00	$71,298.00	171,325
3/27/2023	Dipal Doshi	CEO	Sell	2,000	$14.72	$29,440.00	255,811
1/27/2023	Dipal Doshi	CEO	Sell	2,000	$12.00	$24,000.00	163,835
1/9/2023	Dipal Doshi	CEO	Sell	2,410	$15.02	$36,198.20	165,835
12/29/2022	Dipal Doshi	CEO	Sell	400	$15.01	$6,004.00	168,245
12/27/2022	Dipal Doshi	CEO	Sell	9,669	$15.02	$145,228.38	173,166
12/8/2022	Kory James Wentworth	CFO	Sell	4,550	$18.95	$86,222.50	16,509
12/5/2022	Kory James Wentworth	CFO	Sell	200	$18.05	$3,610.00	16,509
12/2/2022	Kory James Wentworth	CFO	Sell	2,910	$18.20	$52,962.00	16,509

SEC Filings (Institutional Ownership Changes) for Entrada Therapeutics (NASDAQ:TRDA)

86.39% of Entrada Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Entrada Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
12/1/2025	Cantor Fitzgerald L. P.	67,334	$0.39M	0.0%	N/A	0.176%
11/17/2025	Jacobs Levy Equity Management Inc.	315,810	$1.83M	0.0%	+43.1%	0.826%
11/17/2025	NewEdge Advisors LLC	14,167	$82K	0.0%	N/A	0.037%
11/17/2025	XTX Topco Ltd	93,079	$0.54M	0.0%	N/A	0.244%
11/17/2025	Sherbrooke Park Advisers LLC	18,573	$0.11M	0.1%	N/A	0.049%
11/17/2025	Qube Research & Technologies Ltd	287,873	$1.67M	0.0%	+115.3%	0.753%
11/17/2025	Prelude Capital Management LLC	25,754	$0.15M	0.0%	N/A	0.067%
11/17/2025	Public Employees Retirement System of Ohio	28,202	$0.16M	0.0%	+88.0%	0.074%
11/17/2025	Millennium Management LLC	836,609	$4.85M	0.0%	+391.2%	2.189%
11/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	13,108	$76K	0.0%	-14.8%	0.034%
11/17/2025	Jain Global LLC	11,954	$69K	0.0%	N/A	0.031%
11/17/2025	Citadel Advisors LLC	335,741	$1.95M	0.0%	+234.5%	0.878%
11/17/2025	Bank of America Corp DE	126,448	$0.73M	0.0%	+246.7%	0.331%
11/17/2025	Cantor Fitzgerald L. P.	67,334	$0.39M	0.0%	N/A	0.176%
11/17/2025	Algert Global LLC	129,812	$0.75M	0.0%	N/A	0.340%
11/17/2025	Alliancebernstein L.P.	24,320	$0.14M	0.0%	+7.1%	0.064%
11/17/2025	Ameriprise Financial Inc.	69,926	$0.41M	0.0%	+55.6%	0.183%
11/14/2025	Occudo Quantitative Strategies LP	29,486	$0.17M	0.0%	+190.6%	0.077%
11/14/2025	Two Sigma Investments LP	93,194	$0.54M	0.0%	N/A	0.244%
11/14/2025	Bridgeway Capital Management LLC	40,000	$0.23M	0.0%	N/A	0.105%
11/13/2025	BNP Paribas Financial Markets	148,212	$0.86M	0.0%	+4,767.4%	0.388%
11/13/2025	Russell Investments Group Ltd.	8,808	$51K	0.0%	+72.7%	0.023%
11/12/2025	Dimensional Fund Advisors LP	394,279	$2.29M	0.0%	-7.0%	1.032%
11/12/2025	Royce & Associates LP	345,507	$2M	0.0%	+54.8%	0.904%
11/12/2025	Intech Investment Management LLC	13,843	$80K	0.0%	-21.8%	0.036%
11/10/2025	TD Asset Management Inc	37,788	$0.22M	0.0%	-20.9%	0.099%
11/10/2025	AXQ Capital LP	11,570	$67K	0.0%	N/A	0.030%
11/7/2025	GSA Capital Partners LLP	55,960	$0.33M	0.0%	N/A	0.147%
11/7/2025	JPMorgan Chase & Co.	133,878	$0.78M	0.0%	+735.0%	0.352%
11/3/2025	AlphaQuest LLC	6,475	$38K	0.0%	-83.7%	0.017%
11/3/2025	Great Lakes Advisors LLC	41,029	$0.24M	0.0%	N/A	0.108%
10/29/2025	Inscription Capital LLC	11,835	$69K	0.0%	N/A	0.031%
8/19/2025	State of Wyoming	7,575	$51K	0.0%	+130.9%	0.020%
8/15/2025	Man Group plc	16,805	$0.11M	0.0%	N/A	0.044%
8/15/2025	IHT Wealth Management LLC	10,700	$72K	0.0%	N/A	0.028%
8/15/2025	Bank of America Corp DE	36,473	$0.25M	0.0%	+35.6%	0.096%
8/15/2025	5AM Venture Management LLC	4,308,379	$28.95M	11.1%	-2.3%	11.326%
8/15/2025	Ameriprise Financial Inc.	44,946	$0.30M	0.0%	+9.6%	0.118%
8/14/2025	Jane Street Group LLC	51,158	$0.34M	0.0%	N/A	0.134%
8/14/2025	Occudo Quantitative Strategies LP	10,148	$68K	0.0%	N/A	0.027%
8/14/2025	Qube Research & Technologies Ltd	133,730	$0.90M	0.0%	+435.1%	0.352%
8/14/2025	Federated Hermes Inc.	96,686	$0.65M	0.0%	-2.1%	0.254%
8/13/2025	Walleye Capital LLC	17,409	$0.12M	0.0%	N/A	0.046%
8/13/2025	First Trust Advisors LP	75,120	$0.51M	0.0%	+3.6%	0.197%
8/13/2025	Invesco Ltd.	22,393	$0.15M	0.0%	+34.2%	0.059%
8/13/2025	Arrowstreet Capital Limited Partnership	102,008	$0.69M	0.0%	-17.7%	0.268%
8/13/2025	Virtus Investment Advisers LLC	11,979	$80K	0.0%	+32.1%	0.031%
8/12/2025	Prudential Financial Inc.	28,340	$0.19M	0.0%	+23.4%	0.075%
8/12/2025	American Century Companies Inc.	75,094	$0.51M	0.0%	+10.8%	0.197%
8/12/2025	Rhumbline Advisers	39,095	$0.26M	0.0%	+8.3%	0.103%
8/12/2025	Dynamic Technology Lab Private Ltd	24,734	$0.17M	0.0%	N/A	0.065%
8/8/2025	Intech Investment Management LLC	17,702	$0.12M	0.0%	+15.7%	0.047%
8/8/2025	Geode Capital Management LLC	631,554	$4.25M	0.0%	+7.2%	1.664%
8/7/2025	Los Angeles Capital Management LLC	44,632	$0.30M	0.0%	+60.6%	0.118%
8/5/2025	Corton Capital Inc.	28,755	$0.19M	0.2%	N/A	0.076%
7/31/2025	AlphaQuest LLC	39,625	$0.27M	0.0%	+239.8%	0.104%
7/9/2025	Harbor Capital Advisors Inc.	15,277	$0.10M	0.0%	+14.0%	0.040%
6/27/2025	Goldman Sachs Group Inc.	92,540	$0.84M	0.0%	-67.6%	0.244%
5/28/2025	Strs Ohio	41,800	$0.38M	0.0%	N/A	0.110%
5/21/2025	Acadian Asset Management LLC	21,141	$0.19M	0.0%	-58.9%	0.056%
5/16/2025	Goldman Sachs Group Inc.	92,540	$0.84M	0.0%	-67.6%	0.244%
5/16/2025	Jacobs Levy Equity Management Inc.	210,873	$1.91M	0.0%	-0.9%	0.556%
5/16/2025	AQR Capital Management LLC	30,919	$0.28M	0.0%	-43.8%	0.081%
5/15/2025	State of Wyoming	3,280	$30K	0.0%	-45.7%	0.009%
5/15/2025	Trexquant Investment LP	11,143	$0.10M	0.0%	N/A	0.029%
5/14/2025	WCG Wealth Advisors LLC	28,830	$0.26M	0.0%	+20.0%	0.076%
5/14/2025	Merck & Co. Inc.	1,739,768	$15.73M	9.6%	N/A	4.584%
5/14/2025	AlphaQuest LLC	11,662	$0.11M	0.0%	+188.2%	0.031%
5/14/2025	Martingale Asset Management L P	40,163	$0.36M	0.0%	+4.0%	0.106%
5/14/2025	Wellington Management Group LLP	1,053,314	$9.52M	0.0%	+2.1%	2.775%
5/13/2025	American Century Companies Inc.	67,793	$0.61M	0.0%	+13.5%	0.179%
5/12/2025	Nuveen LLC	67,016	$0.61M	0.0%	N/A	0.177%
5/12/2025	Invesco Ltd.	16,691	$0.15M	0.0%	+45.1%	0.044%
5/12/2025	Connor Clark & Lunn Investment Management Ltd.	11,553	$0.10M	0.0%	-86.5%	0.030%
5/9/2025	Deutsche Bank AG	19,504	$0.18M	0.0%	-10.3%	0.051%
5/9/2025	Charles Schwab Investment Management Inc.	192,717	$1.74M	0.0%	-2.2%	0.508%
5/7/2025	Mackenzie Financial Corp	18,396	$0.17M	0.0%	+26.9%	0.048%
5/2/2025	Massachusetts Financial Services Co. MA	86,310	$0.78M	0.0%	+28.1%	0.227%
4/29/2025	Bank of New York Mellon Corp	100,060	$0.91M	0.0%	-1.3%	0.266%
4/24/2025	Allspring Global Investments Holdings LLC	17,020	$0.15M	0.0%	+53.0%	0.045%
4/14/2025	Harbor Capital Advisors Inc.	13,403	$0.12M	0.0%	N/A	0.036%
3/24/2025	Wellington Management Group LLP	1,031,826	$17.84M	0.0%	+0.2%	2.745%
2/20/2025	Mackenzie Financial Corp	14,500	$0.25M	0.0%	N/A	0.039%
2/19/2025	WCG Wealth Advisors LLC	24,030	$0.42M	0.0%	+6.2%	0.064%
2/19/2025	Public Employees Retirement System of Ohio	17,259	$0.30M	0.0%	+6.2%	0.046%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	35,750	$0.62M	0.0%	+152.5%	0.096%
2/17/2025	State of Wyoming	6,037	$0.10M	0.0%	N/A	0.016%
2/17/2025	MPM Asset Management LLC	4,381,062	$75.75M	60.9%	-1.0%	11.708%
2/17/2025	Nuveen Asset Management LLC	87,506	$1.51M	0.0%	-32.6%	0.234%
2/17/2025	Millennium Management LLC	12,527	$0.22M	0.0%	-88.7%	0.033%
2/17/2025	Lazard Asset Management LLC	55,517	$0.96M	0.0%	+40.8%	0.148%
2/17/2025	Jacobs Levy Equity Management Inc.	212,717	$3.68M	0.0%	+5.4%	0.568%
2/17/2025	Janus Henderson Group PLC	2,080,367	$36.01M	0.0%	+21.6%	5.560%
2/17/2025	Deutsche Bank AG	21,740	$0.38M	0.0%	+55.5%	0.058%
2/17/2025	Bank of America Corp DE	35,721	$0.62M	0.0%	+4.9%	0.095%
2/17/2025	BNP Paribas Financial Markets	3,324	$57K	0.0%	N/A	0.009%
2/17/2025	Ameriprise Financial Inc.	40,624	$0.70M	0.0%	+6.6%	0.109%
2/14/2025	Northern Trust Corp	318,177	$5.50M	0.0%	+28.5%	0.850%
2/14/2025	Virtus ETF Advisers LLC	3,924	$68K	0.0%	N/A	0.010%
2/14/2025	Price T Rowe Associates Inc. MD	2,903,025	$50.19M	0.0%	-4.8%	7.758%

Data available starting January 2016

Entrada Therapeutics, Inc., a clinical-stage biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its EEV platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. Its therapeutic candidates, which include ENTR-601-44, which is in Phase I clinical trial for the treatment of Duchenne muscular dystrophy; and ENTR-701, which is in Phase 1/2 clinical trial for the treatment of myotonic dystrophy type 1. The company also offers ENTR-601-45 and ENTR-601-50, which are in preclinical trail for the treatment of Duchenne muscular dystrophy; and ENTR-501, an intracellular thymidine phosphorylase enzyme replacement therapy, which is in preclinical trail for the treatment of mitochondrial neurogastrointestinal encephalomyopathy. Entrada Therapeutics, Inc. has a strategic collaboration and license agreement with Vertex Pharmaceuticals Incorporated to research, develop, manufacture, and commercialize ENTR-701. The company was formerly known as CycloPorters, Inc. and changed its name to Entrada Therapeutics, Inc. in October 2017. Entrada Therapeutics, Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.

Today's Range

Now: $10.16

$9.52

$10.38

50 Day Range

MA: $7.48

$5.80

$10.26

52 Week Range

Now: $10.16

$4.93

$21.79

Volume

123,914 shs

Average Volume

286,123 shs

Market Capitalization

$388.32 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Entrada Therapeutics?: Entrada Therapeutics' top insider shareholders include:
Bros Advisors Lp Baker (Major Shareholder)
Bioventures 2018 LP Mpm (Major Shareholder)
Ventures V LP 5Am (Major Shareholder)
Kush Parmar (Director)
Dipal Doshi (CEO)
Natarajan Sethuraman (Insider)
Nathan J Dowden (COO)
Kory James Wentworth (CFO)
Peter S Kim (Director)
Learn More about top insider investors at Entrada Therapeutics.
Who are the major institutional investors of Entrada Therapeutics?: Entrada Therapeutics' top institutional shareholders include:
Millennium Management LLC — 2.19%
Dimensional Fund Advisors LP — 1.03%
Royce & Associates LP — 0.90%
Citadel Advisors LLC — 0.88%
Jacobs Levy Equity Management Inc. — 0.83%
Qube Research & Technologies Ltd — 0.75%
Learn More about top institutional investors of Entrada Therapeutics stock.
Which institutional investors are selling Entrada Therapeutics stock?: Within the last quarter, TRDA stock was sold by these institutional investors:
AlphaQuest LLC
Dimensional Fund Advisors LP
TD Asset Management Inc
Intech Investment Management LLC
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.
Within the last year, company insiders that have sold Entrada Therapeutics company stock include:
Bros Advisors Lp Baker (Major Shareholder)
Bioventures 2018 LP Mpm (Major Shareholder)
Ventures V LP 5Am (Major Shareholder)
Kush Parmar (Director)
Learn More investors selling Entrada Therapeutics stock.
Which institutional investors are buying Entrada Therapeutics stock?: In the previous quarter, TRDA stock was bought by institutional investors including:
Millennium Management LLC
Citadel Advisors LLC
Qube Research & Technologies Ltd
BNP Paribas Financial Markets
Algert Global LLC
Royce & Associates LP
JPMorgan Chase & Co.
Jacobs Levy Equity Management Inc.
Within the previous year, these company insiders have bought Entrada Therapeutics stock:
Bros Advisors Lp Baker (Major Shareholder)
Bioventures 2018 LP Mpm (Major Shareholder)
Learn More investors buying Entrada Therapeutics stock.